000 -LEADER |
fixed length control field |
01150cam a2200325 a 4500 |
001 - CONTROL NUMBER |
control field |
vtls003228876 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
MY-SjTCS |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20200226115132.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
120119s2012 paua b 001 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780323074452 (pbk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0323074456 (pbk.) |
039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
Level of rules in bibliographic description |
201303121532 |
Level of effort used to assign nonsubject heading access points |
wilmina |
Level of effort used to assign subject headings |
201203231159 |
Level of effort used to assign classification |
wilmina |
Level of effort used to assign subject headings |
201203151520 |
Level of effort used to assign classification |
stazrina |
-- |
201201191730 |
-- |
malathy |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1 |
Item number |
KES 2012 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Kester, Mark. |
9 (RLIN) |
56027 |
245 10 - TITLE STATEMENT |
Title |
Elsevier's integrated review. |
Name of part/section of a work |
Pharmacology / |
Statement of responsibility, etc. |
Mark Kester, Kelly D. Karpa, Kent E. Vrana. |
246 1# - VARYING FORM OF TITLE |
Title proper/short title |
Integrated review pharmacology |
250 ## - EDITION STATEMENT |
Edition statement |
2nd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Philadelphia : |
Name of publisher, distributor, etc. |
Elsevier/Saunders, |
Date of publication, distribution, etc. |
c2012. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
x, 245 p. : |
Other physical details |
col. ill. ; |
Dimensions |
28 cm. |
500 ## - GENERAL NOTE |
General note |
Rev. ed. of: Elsevier's integrated pharmacology / Mark Kester ... [et al.]. c2007. |
500 ## - GENERAL NOTE |
General note |
Includes index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Administration |
9 (RLIN) |
41539 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Therapeutics. |
9 (RLIN) |
20427 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Karpa, Kelly D. |
9 (RLIN) |
58948 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Vrana, Kent E. |
9 (RLIN) |
58947 |
730 0# - ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Elsevier's integrated pharmacology. |
920 ## - Programme |
Programme |
BMS : 178665 |
921 ## - Programme |
Programme |
PHA : 195698 |
999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
Koha biblionumber |
143766 |
Koha biblioitemnumber |
143766 |